Valsartan Lawyers To Be Appointed To Leadership Position After Next MDL Conference
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.…
«
»
A federal judge is expected to select attorneys for leadership positions in valsartan recall litigation by the end of the month.…
Plaintiffs can now file valsartan recall lawsuits over cancer injuries directly with the MDL court in New Jersey…
The FDA is providing a list of 40 blood pressure medications it says are free of cancer-causing impurities, but warns that shortages will increase beyond valsartan.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
The initial status conference for federal valsartan recall litigation is scheduled for March 27.…
A new editorial looks at the massive number of valsartan recalls as a stress test of the U.S. drug supply chain and call for the FDA and pharmacies to learn from the experience.…
The FDA has fast-tracked approval of a new generic valsartan tablet in the face of shortages due to recalls over cancer-causing impurities.…
Deadlines in federal valsartan recall lawsuits have been suspended until the first initial status conference later this month as part of the recently-formed MDL.…
In response to growing concerns about the safety of generic drugs, which emerged following recent valsartan recalls issued over cancer-causing impurities, federal regulators are defending their oversight and monitoring of generic manufacturers.…
Cancer-causing impurities found in recalled valsartan may have been the result of a process that sought to make more of the hypertension drug at a faster pace.…